Abramson Cancer Center University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center University of Pennsylvania has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Head and Neck, Squamous Cell Cancer, Incurable Platinum Refractory Germ Cell Tumors.

Sponsors: Memorial Sloan Kettering Cancer Center, Astellas Pharma Global Development, Inc., Ono Pharmaceutical Co. Ltd.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center University of Pennsylvania?

Abramson Cancer Center University of Pennsylvania has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center University of Pennsylvania conducted?

Abramson Cancer Center University of Pennsylvania has 3 clinical trials on record, with 1 currently active. Their work covers Head and Neck, Squamous Cell Cancer, Incurable Platinum Refractory Germ Cell Tumors.

Is Abramson Cancer Center University of Pennsylvania accredited by Crixeo Health?

Abramson Cancer Center University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.